It's been a busy week - the show kicked off with the traditional opening keynote from Salesforce Chair, CEO & Co-Founder Marc ...

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

Patients with a very rare immune disorder who have gotten the gene therapy have experienced sustained long-term immune ...